MedTrace Logo

Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

NCT07486986 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2026-03-23

No results posted yet for this study

Summary

EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.

Conditions

Interventions

OTHER

4 years of clinical evaluations.

The intervention in this study is the additional clinical evaluations for women with type 2 DM and in perimenopause.

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    lead OTHER

Principal Investigators

  • Kerri Anne Mullen, Ph.D. · Ottawa Heart Institute Research Corporation

Eligibility

Min Age
48 Years
Max Age
58 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2032-12-31
Completion
2032-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07486986 on ClinicalTrials.gov